Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF versus TDF for prevention of mother-to-child transmission of hepatitis B in pregnant women
ChiCTR1900024195Phase 4Not yet recruiting
- Sponsor
- Shenyang Sixth People's Hospital
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide and tenofovir disoproxil fumarate in hepatitis B (HBV) (2 arms), sponsored by Shenyang Sixth People's Hospital. Primary endpoint: Virological response. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
tenofovir alafenamidetenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR1900024195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024195.